- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Moderate to severe ulcerative colitis (MUSC)
- Meeting Date: July 2023
- Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 1.1MB)
- Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 231KB)
Mirikizumab – July 2023
Mirikizumab: Solution concentrate for I.V. infusion 300 mg in 15 mL, Solution for injection 100 mg in 1 mL pre filled pen; Omvoh®
Last updated
27 October 2023